Stock Information
Contineum Therapeutics Inc (CTNM)
Ticker Symbol: CTNM
Exchange: NASDAQ
Sector: Pharmaceuticals
Market Cap: $624.35 mil
Piotroski score: 4
PE Ratio: N/A
EPS (TTM): -1.74
Revenue (TTM): $0.00 M
Dividend Yield: N/A
ROE: -24.73%
Latest News
-
Morgan Stanley Maintains Equal-Weight on Contineum Therapeutics, Lowers Price Target to $17
Mon, Sep 28, 2026 9:06 AM
-
J&J and Contineum’s Depression Drug Missed Phase 2 Goal. What Comes Next?
Thu, Sep 24, 2026 11:04 PM
Key Financials
Financial data not available
